https://www.selleckchem.com/pr....oducts/enfortumab-ve
For patients with BDD, initial treatments for monotherapy or combination therapy are SSRIs and/or CBT tailored to BDD. For patients with severe BDD or signs of suicidality, combination therapy should be used.Personality disorders (PDs) have a prevalence of approximately 9% in the United States. Patients with these disorders frequently are encountered in the family medicine setting. It is thought that a combination of unknown genetic factors and life experiences, particularly adverse childhood experiences, contribute to P
Like
Comment
Share
